{"id":"zotarolimus","rwe":[{"pmid":"41879601","year":"2026","title":"\"Roundabout\" Bailout Stenting for Subacute Right Coronary Artery Obstruction After Self-Expandable Transcatheter Aortic Valve Replacement.","finding":"","journal":"JACC. Case reports","studyType":"Clinical Study"},{"pmid":"41631490","year":"2026","title":"Comparative effectiveness of percutaneous coronary intervention strategies for coronary small-vessel disease: a network meta-analysis of randomized trials.","finding":"","journal":"Annals of medicine","studyType":"Clinical Study"},{"pmid":"41561403","year":"2026","title":"Short dual antiplatelet therapy after PCI with Resolute Onyx drug-eluting stents in high bleeding risk patients: One-year outcomes from a South Asian cohort.","finding":"","journal":"American heart journal plus : cardiology research and practice","studyType":"Clinical Study"},{"pmid":"41230396","year":"2025","title":"Complex all-comers and patients with diabetes and prediabetes treated with Xience Sierra everolimus-eluting stents: COASTLINE high-risk.","finding":"","journal":"European heart journal open","studyType":"Clinical Study"},{"pmid":"41194756","year":"2025","title":"Economic Outcomes and Quality of Life After CABG or PCI for Multivessel Disease: The FAME 3 Trial.","finding":"","journal":"Journal of the American College of Cardiology","studyType":"Clinical Study"}],"tags":[{"label":"zotarolimus","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Peptidyl-prolyl cis-trans isomerase FKBP1A","category":"target"},{"label":"FKBP1A","category":"gene"},{"label":"MTOR","category":"gene"},{"label":"Active","category":"status"}],"phase":"phase_3","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["ABT-578","ABT578","zotarolimus"],"offLabel":[],"synonyms":["ABT-578","ABT578","zotarolimus"],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"target":"Peptidyl-prolyl cis-trans isomerase FKBP1A, Serine/threonine-protein kinase mTOR","targets":[{"gene":"FKBP1A","source":"DrugCentral","target":"Peptidyl-prolyl cis-trans isomerase FKBP1A","protein":"Peptidyl-prolyl cis-trans isomerase FKBP1A"},{"gene":"MTOR","source":"DrugCentral","target":"Serine/threonine-protein kinase mTOR","protein":"Serine/threonine-protein kinase mTOR"}],"modality":"Small Molecule","drugClass":"zotarolimus","explanation":"Think of it like a key fitting into a lock. Zotarolimus is the key that blocks the action of FKBP1A, which is like a switch that turns on T-cell activation. By blocking this switch, zotarolimus helps to prevent the immune system from attacking the transplanted heart tissue.","oneSentence":"Zotarolimus works by binding to the FKBP1A protein, which is involved in the activation of calcineurin and subsequent T-cell activation.","technicalDetail":"Zotarolimus binds to FKBP1A, inhibiting its peptidyl-prolyl cis-trans isomerase activity, which is necessary for the activation of calcineurin and subsequent T-cell activation, thereby preventing immune cell proliferation and graft rejection."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2949","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=ZOTAROLIMUS","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ZOTAROLIMUS","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T16:16:37.438425","biosimilars":[],"competitors":[{"drugName":"ciclosporin","drugSlug":"ciclosporin","fdaApproval":"1983-11-14","relationship":"same-target"},{"drugName":"everolimus","drugSlug":"everolimus","fdaApproval":"2009-03-30","patentExpiry":"May 1, 2026","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"pimecrolimus","drugSlug":"pimecrolimus","fdaApproval":"2001-12-13","genericCount":2,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"sirolimus","drugSlug":"sirolimus","fdaApproval":"1999-09-15","patentExpiry":"Oct 28, 2040","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"tacrolimus","drugSlug":"tacrolimus","fdaApproval":"1994-04-08","patentExpiry":"May 30, 2028","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"temsirolimus","drugSlug":"temsirolimus","fdaApproval":"2007-05-30","patentExpiry":"Nov 10, 2032","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"thiabendazole","drugSlug":"thiabendazole","fdaApproval":"1967-04-07","patentStatus":"Unknown","relationship":"same-target"}],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"zotarolimus","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"ciclosporin","brandName":"ciclosporin","genericName":"ciclosporin","approvalYear":"1983","relationship":"same-target"},{"drugId":"everolimus","brandName":"everolimus","genericName":"everolimus","approvalYear":"2009","relationship":"same-target"},{"drugId":"pimecrolimus","brandName":"pimecrolimus","genericName":"pimecrolimus","approvalYear":"2001","relationship":"same-target"},{"drugId":"sirolimus","brandName":"sirolimus","genericName":"sirolimus","approvalYear":"1999","relationship":"same-target"},{"drugId":"tacrolimus","brandName":"tacrolimus","genericName":"tacrolimus","approvalYear":"1994","relationship":"same-target"},{"drugId":"temsirolimus","brandName":"temsirolimus","genericName":"temsirolimus","approvalYear":"2007","relationship":"same-target"},{"drugId":"thiabendazole","brandName":"thiabendazole","genericName":"thiabendazole","approvalYear":"1967","relationship":"same-target"}],"trialDetails":[{"nctId":"NCT02100722","phase":"NA","title":"A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease","status":"COMPLETED","sponsor":"Stanford University","startDate":"2014-08-25","conditions":["Coronary Disease","Coronary Stenosis"],"enrollment":1500,"completionDate":"2024-12-01"},{"nctId":"NCT06013007","phase":"NA","title":"Joint Inflation With Nominal-pressure and Stability Approach in DES Optimization","status":"COMPLETED","sponsor":"Zunyi Medical College","startDate":"2023-08-22","conditions":["Acute Coronary Syndrome","De Novo Stenosis"],"enrollment":161,"completionDate":"2026-03-05"},{"nctId":"NCT03466151","phase":"NA","title":"RESOLUTE ONYX China RCT Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medtronic Vascular","startDate":"2018-04-12","conditions":["Ischemic Heart Disease","Stenotic Coronary Lesion","Cardiovascular Diseases","Arteriosclerosis","Coronary Artery Disease"],"enrollment":550,"completionDate":"2026-04-30"},{"nctId":"NCT03471845","phase":"NA","title":"RESOLUTE ONYX China Single Arm Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medtronic Vascular","startDate":"2018-03-30","conditions":["Ischemic Heart Disease","Stenotic Coronary Lesion","Cardiovascular Diseases","Arteriosclerosis","Coronary Artery Disease"],"enrollment":591,"completionDate":"2026-04-30"},{"nctId":"NCT05340361","phase":"","title":"Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2022-03-23","conditions":["Coronary Artery Disease","Optical Coherence Tomography","Stent"],"enrollment":30,"completionDate":"2026-12-31"},{"nctId":"NCT06271590","phase":"NA","title":"MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels","status":"RECRUITING","sponsor":"Concept Medical Inc.","startDate":"2025-05-20","conditions":["Coronary Artery Disease","Native Coronary Artery Stenosis","Cardiovascular Diseases"],"enrollment":1605,"completionDate":"2031-11"},{"nctId":"NCT04192747","phase":"NA","title":"The Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries","status":"ACTIVE_NOT_RECRUITING","sponsor":"Elixir Medical Corporation","startDate":"2020-12-16","conditions":["Coronary Artery Disease","Coronary Artery Stenosis","Coronary Disease","Coronary Stenosis"],"enrollment":445,"completionDate":"2027-02-28"},{"nctId":"NCT03376646","phase":"NA","title":"A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary Small Vessel Disease","status":"COMPLETED","sponsor":"DK Medical Technology (Suzhou) Co., Ltd.","startDate":"2018-06-20","conditions":["Coronary Small Vessel Disease"],"enrollment":277,"completionDate":"2024-04-15"},{"nctId":"NCT06822322","phase":"NA","title":"The European Bifurcation Club Randomized Trial of Stepwise Provisional Stenting Versus Drug Coated Balloon Therapy for Non-left Main True Coronary Bifurcations","status":"NOT_YET_RECRUITING","sponsor":"Ceric Sàrl","startDate":"2025-05","conditions":["Coronary Artery Disease (non-left Main)","Coronary Bifurcation Lesion"],"enrollment":750,"completionDate":"2035-08"},{"nctId":"NCT05320926","phase":"NA","title":"Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2022-07-26","conditions":["Ischemic Heart Disease"],"enrollment":3744,"completionDate":"2028-07-10"},{"nctId":"NCT04562805","phase":"NA","title":"Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Elixir Medical Corporation","startDate":"2020-09-30","conditions":["Coronary Artery Disease","Ischemic Heart Disease"],"enrollment":2400,"completionDate":"2028-07-31"},{"nctId":"NCT06577896","phase":"","title":"The Study to Evaluate the Safety and Efficacy of the Onyx Family","status":"RECRUITING","sponsor":"Pusan National University Yangsan Hospital","startDate":"2022-06-09","conditions":["Coronary Artery Disease"],"enrollment":500,"completionDate":"2026-12-31"},{"nctId":"NCT04562532","phase":"NA","title":"Firehawk Rapamycin Target Eluting Coronary Stent North American Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shanghai MicroPort Medical (Group) Co., Ltd.","startDate":"2021-02-17","conditions":["Coronary Artery Disease"],"enrollment":1720,"completionDate":"2027-06-30"},{"nctId":"NCT04937803","phase":"NA","title":"Safety and Efficacy of Drug-Coated Balloon for De-novo Lesions in Patients With Acute Coronary Syndromes (DCB-ACS)","status":"COMPLETED","sponsor":"Harbin Medical University","startDate":"2021-04-19","conditions":["Drug-Coated Balloon","De Novo Stenosis","Acute Coronary Syndromes","ACS","DCB","Clinical Trial","Coronary Artery Disease"],"enrollment":216,"completionDate":"2023-11-17"},{"nctId":"NCT04825886","phase":"","title":"Efficacy and Safety of ZotaRolimus-Eluting Coronary Stent System In Patients With Long Coronary Artery Disease","status":"COMPLETED","sponsor":"Chonnam National University Hospital","startDate":"2017-12-28","conditions":["Coronary Artery Disease","Myocardial Ischemia","Coronary Disease"],"enrollment":2000,"completionDate":"2022-03-18"},{"nctId":"NCT05209412","phase":"NA","title":"Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery Lesions","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2022-02-01","conditions":["De Novo Stenosis","Coronary Artery Disease","Percutaneous Coronary Intervention"],"enrollment":370,"completionDate":"2025-02-01"},{"nctId":"NCT03584464","phase":"NA","title":"RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2018-05-14","conditions":["Coronary Artery Disease"],"enrollment":205,"completionDate":"2022-09-28"},{"nctId":"NCT03063749","phase":"","title":"RESOLUTE ONYX Post-Approval Study","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2017-03-30","conditions":["Coronary Artery Disease"],"enrollment":416,"completionDate":"2022-08-18"},{"nctId":"NCT01995487","phase":"NA","title":"Study of BioNIR Drug Eluting Stent System in Coronary Stenosis","status":"COMPLETED","sponsor":"Medinol Ltd.","startDate":"2014-01","conditions":["Coronary Artery Stenosis"],"enrollment":1919,"completionDate":"2020-11-30"},{"nctId":"NCT03118531","phase":"NA","title":"China Resolute Integrity 34/38 mm Study","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2017-04-17","conditions":["Ischemic Heart Disease","Stenotic Coronary Lesion","Cardiovascular Diseases","Arteriosclerosis","Coronary Artery Disease"],"enrollment":40,"completionDate":"2023-04-28"},{"nctId":"NCT04465669","phase":"NA","title":"Heterogeneity of Neointimal Healing Following Biodegradable-polymer Drug-Eluting Coronary Stent Implantation","status":"COMPLETED","sponsor":"Tomsk National Research Medical Center of the Russian Academy of Sciences","startDate":"2020-01-13","conditions":["Coronary Heart Disease","Stable Angina Pectoris","Silent Myocardial Ischemia"],"enrollment":50,"completionDate":"2022-12-31"},{"nctId":"NCT00422565","phase":"PHASE4","title":"Zotarolimus-Versus Sirolimus-Versus PacliTaxel-Eluting Stent for Acute Myocardial Infarction Patients","status":"TERMINATED","sponsor":"Seung-Jung Park","startDate":"2006-10","conditions":["Myocardial Infarction"],"enrollment":328,"completionDate":"2008-09"},{"nctId":"NCT01735656","phase":"NA","title":"Comparison of Double Kissing Culotte Stenting With Double Kissing Crush Stenting for True Bifurcation Lesions","status":"COMPLETED","sponsor":"Fujian Medical University","startDate":"2014-03","conditions":["Coronary Heart Disease"],"enrollment":328,"completionDate":"2021-12-30"},{"nctId":"NCT02098876","phase":"NA","title":"Wall Shear Stress and Neointimal Healing Following PCI in Angulated Coronary Vessels","status":"COMPLETED","sponsor":"Emory University","startDate":"2014-05","conditions":["Coronary Artery Disease"],"enrollment":86,"completionDate":"2020-12"},{"nctId":"NCT01674803","phase":"NA","title":"Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion (BIO-RESORT)","status":"COMPLETED","sponsor":"Foundation of Cardiovascular Research and Education Enschede","startDate":"2012-12-21","conditions":["Acute Coronary Syndrome","Angina Pectoris","Angina, Unstable","Myocardial Infarction","Coronary Artery Disease","Coronary Stenosis","Coronary Restenosis"],"enrollment":3514,"completionDate":"2020-08-25"},{"nctId":"NCT05417893","phase":"NA","title":"Non-inferiority Clinical Trial to Compare the Safety and Performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions","status":"NOT_YET_RECRUITING","sponsor":"Meril Life Sciences Pvt. Ltd.","startDate":"2022-10-15","conditions":["Coronary Artery Disease"],"enrollment":1872,"completionDate":"2028-06-15"},{"nctId":"NCT00704561","phase":"NA","title":"Vessel Wall Response of the Zotarolimus Drug-eluting Stent Implanted in AMI Assessed by Optical Coherence Tomography","status":"COMPLETED","sponsor":"A.O. Ospedale Papa Giovanni XXIII","startDate":"2008-04","conditions":["Acute Myocardial Infarction"],"enrollment":44,"completionDate":"2009-10"},{"nctId":"NCT05240781","phase":"NA","title":"Zotarolimus vs Sirolimus Eluting Stent in High Bleeding Risk","status":"UNKNOWN","sponsor":"Instituto Nacional de Cardiologia Ignacio Chavez","startDate":"2021-09-29","conditions":["High Bleeding Risk","Coronary Artery Disease","Percutaneous Coronary Intervention"],"enrollment":280,"completionDate":"2025-02-28"},{"nctId":"NCT03647475","phase":"NA","title":"A Single Arm Trial With Resolute Onyx in ONE-Month DAPT for High-Bleeding Risk Patients Who Are Considered One-Month Clear (Onyx ONE Clear)","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2018-10-01","conditions":["Coronary Artery Disease"],"enrollment":752,"completionDate":"2021-04-22"},{"nctId":"NCT04885816","phase":"NA","title":"Drug-eluting Balloon Versus Drug-eluting Stent for High Bleeding Risk Angioplasty","status":"TERMINATED","sponsor":"Instituto Nacional de Cardiologia Ignacio Chavez","startDate":"2021-04-20","conditions":["High Bleeding Risk","Coronary Artery Disease (CAD)","Percutaneous Coronary Intervention (PCI)"],"enrollment":5,"completionDate":"2021-09-29"},{"nctId":"NCT01947439","phase":"NA","title":"Comparison of the Biolimus A9-eluting Stent With the Zotarolimus -Eluting Stent in Multi-vessel PCI","status":"COMPLETED","sponsor":"Keimyung University Dongsan Medical Center","startDate":"2013-03","conditions":["Multivessel Coronary Artery Disease"],"enrollment":932,"completionDate":"2021-06"},{"nctId":"NCT04785846","phase":"","title":"Registry of RESOLUTE-ONYX™ Zotarolimus-eluting Stent Utilization in Percutaneous Small Vessel Coronary Interventionism.","status":"COMPLETED","sponsor":"Fundación Investigación Sanitaria en León","startDate":"2017-10-18","conditions":["Coronary Disease","Angina, Stable","Ischemia","Acute Coronary Syndrome","Percutaneous Coronary Intervention"],"enrollment":307,"completionDate":"2020-02-17"},{"nctId":"NCT01995500","phase":"PHASE2","title":"Angiography Study of BioNIR Drug Eluting Stent System (NIREUS)","status":"COMPLETED","sponsor":"Medinol Ltd.","startDate":"2014-03-19","conditions":["Coronary Artery Stenosis"],"enrollment":300,"completionDate":"2020-06-17"},{"nctId":"NCT03321032","phase":"PHASE4","title":"Second-generation Drug-eluting Stents in Diabetes","status":"UNKNOWN","sponsor":"Spanish Society of Cardiology","startDate":"2017-12-19","conditions":["Coronary Artery Disease","Diabetes Mellitus"],"enrollment":1164,"completionDate":"2022-01-28"},{"nctId":"NCT03344653","phase":"NA","title":"A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2017-11-02","conditions":["Coronary Artery Disease"],"enrollment":2000,"completionDate":"2020-10-09"},{"nctId":"NCT00963781","phase":"PHASE4","title":"Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside)","status":"COMPLETED","sponsor":"Scripps Health","startDate":"2009-08","conditions":["Coronary Artery Disease","Coronary Thrombosis"],"enrollment":219,"completionDate":"2013-08"},{"nctId":"NCT02236975","phase":"PHASE2,PHASE3","title":"First-in-man Trial Examining the Safety and Efficacy of BuMA Supreme and Resolute Integrity in Patients With de Novo Coronary Artery Stenosis","status":"COMPLETED","sponsor":"Sino Medical Sciences Technology Inc.","startDate":"2015-04","conditions":["Coronary Artery Disease"],"enrollment":168,"completionDate":"2019-03"},{"nctId":"NCT02099162","phase":"","title":"Yonsei OCT (Optical Coherence Tomography) Registry for Evaluation of Efficacy and Safety of Coronary Stenting","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2007-08","conditions":["Coronary Artery Disease","Ischemic Heart Disease"],"enrollment":3000,"completionDate":"2022-07"},{"nctId":"NCT00792753","phase":"NA","title":"Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study \"EXCELLA II STUDY\"","status":"COMPLETED","sponsor":"Elixir Medical Corporation","startDate":"2008-10","conditions":["Coronary Artery Disease"],"enrollment":360,"completionDate":"2014-03-08"},{"nctId":"NCT01003717","phase":"","title":"Registry Experience at the Washington Hospital Center, DES - Endeavor for Myocardial Infarction","status":"COMPLETED","sponsor":"Rebecca Torguson","startDate":"2009-10","conditions":["Coronary Artery Disease"],"enrollment":120,"completionDate":"2013-10"},{"nctId":"NCT02946307","phase":"NA","title":"Assess the Efficacy and Safety of RESTORE Paclitaxel Eluting Balloon Versus RESOLUTE Zotarolimus Eluting Stent for the Treatment of Small Coronary Vessel Disease","status":"COMPLETED","sponsor":"ZhuHai Cardionovum Medical Device Co., Ltd.","startDate":"2016-08","conditions":["Coronary Stenosis"],"enrollment":240,"completionDate":"2019-05"},{"nctId":"NCT01397175","phase":"NA","title":"BES, EES, and ZES-R in Real World Practice","status":"TERMINATED","sponsor":"Yonsei University","startDate":"2013-01-16","conditions":["Coronary Artery Disease"],"enrollment":1960,"completionDate":"2019-01-01"},{"nctId":"NCT02412501","phase":"NA","title":"Medtronic Resolute Onyx 2.0 mm Clinical Study","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2015-04-06","conditions":["Coronary Artery Disease"],"enrollment":101,"completionDate":"2019-02-21"},{"nctId":"NCT01913600","phase":"NA","title":"Resolute Integrity US Extended Length Sub-Study(RI US XL)","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2013-07","conditions":["Coronary Artery Disease"],"enrollment":56,"completionDate":"2018-12"},{"nctId":"NCT02419521","phase":"NA","title":"Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2015-07-07","conditions":["Coronary Artery Disease"],"enrollment":75,"completionDate":"2018-12-03"},{"nctId":"NCT01638507","phase":"NA","title":"An Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2012-07","conditions":["Coronary Artery Disease"],"enrollment":230,"completionDate":"2015-06"},{"nctId":"NCT01979744","phase":"NA","title":"Intravascular ULTrasound Guided Versus Conventional Angiography Guided Strategy to Deploy Zotarolimus and Everolimus Eluting Third Generation Stents in the Long Coronary Artery Lesions: ULTRA-ZET Trial","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2013-10","conditions":["Coronary Artery Disease"],"enrollment":568,"completionDate":"2017-10-31"},{"nctId":"NCT01073111","phase":"NA","title":"Assessment of Stent Strut Coverage and Endothelial Function After Drug-Eluting Stents","status":"WITHDRAWN","sponsor":"Hyogo Medical University","startDate":"2010-04","conditions":["Coronary Artery Disease","Atherosclerosis"],"enrollment":0,"completionDate":"2017-02"},{"nctId":"NCT01722799","phase":"NA","title":"Randomized Trial of Coronary Angioplasty for de Novo Lesions in sMall vesSElS With Drug Eluting Balloon.","status":"COMPLETED","sponsor":"Andres Iñiguez Romo, MD, PhD","startDate":"2012-12","conditions":["Coronary Disease"],"enrollment":97,"completionDate":"2018-04-06"},{"nctId":"NCT02809248","phase":"NA","title":"The Influence Cirrhosis of the Liver on the Coronary Re-stenosis (LTX- Stent Study)","status":"WITHDRAWN","sponsor":"RWTH Aachen University","startDate":"2016-07","conditions":["Re-stenosis","Cirrhosis of the Liver"],"enrollment":0,"completionDate":"2017-12-31"},{"nctId":"NCT02328898","phase":"PHASE4","title":"Randomized \"All-comer\" Evaluation of a Permanent Polymer Resolute Integrity Stent Versus a Polymer Free Cre8 Stent","status":"UNKNOWN","sponsor":"UMC Utrecht","startDate":"2014-11","conditions":["Stable Angina Pectoris","Acute Coronary Syndrome"],"enrollment":1532,"completionDate":"2020-09"},{"nctId":"NCT03507205","phase":"","title":"Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2008-04-01","conditions":["Coronary Artery Disease"],"enrollment":17286,"completionDate":"2017-11-30"},{"nctId":"NCT01243749","phase":"","title":"RESOLUTE China Registry:","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2010-12","conditions":["Ischemic Heart Disease","Stenotic Coronary Lesion","Cardiovascular Diseases","Arteriosclerosis","Coronary Artery Disease"],"enrollment":1800,"completionDate":"2017-12-15"},{"nctId":"NCT01382043","phase":"","title":"Angiographic and IVUS Follow-up After Simultaneously Implanted Different Drug-eluting Stents in Same Individuals (AIFSIDDES)","status":"COMPLETED","sponsor":"Liuhuaqiao Hospital","startDate":"2009-06","conditions":["Percutaneous Coronary Angioplasty"],"enrollment":48,"completionDate":"2011-01"},{"nctId":"NCT02770651","phase":"","title":"Late Stent Strut Apposition and Coverage After Drug-Eluting Stent Implantation by OCT in Patients With AMI","status":"UNKNOWN","sponsor":"Keimyung University Dongsan Medical Center","startDate":"2016-05","conditions":["Coronary Artery Disease","Coronary Disease","Myocardial Ischemia","Arterial Occlusive Diseases","Arteriosclerosis","Cardiovascular Diseases","Heart Diseases","Vascular Diseases"],"enrollment":69,"completionDate":"2018-12"},{"nctId":"NCT01334268","phase":"NA","title":"RESOLUTE China RCT","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2011-09","conditions":["Ischemic Heart Disease","Stenotic Coronary Lesion","Cardiovascular Diseases","Arteriosclerosis","Coronary Artery Disease"],"enrollment":400,"completionDate":"2017-06-30"},{"nctId":"NCT00977938","phase":"PHASE4","title":"The Dual Antiplatelet Therapy Study (DAPT Study)","status":"COMPLETED","sponsor":"Baim Institute for Clinical Research","startDate":"2009-10","conditions":["Coronary Artery Disease"],"enrollment":25682,"completionDate":"2014-06"},{"nctId":"NCT03151018","phase":"","title":"Effect and Efficacy of Onyx™, Zotarolimus-eluting Stent for Coronary Atherosclerosis","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2015-05","conditions":["Coronary Artery Disease","Acute Coronary Syndrome","Myocardial Infarction","Angina Pectoris"],"enrollment":4000,"completionDate":"2021-05"},{"nctId":"NCT01150500","phase":"NA","title":"RESOLUTE Japan SVS: The Clinical Evaluation of the MDT-4107 DES in the Treatment of De Novo Lesions in Small Diameter Native Coronary Arteries","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2010-06","conditions":["Arterial Occlusive Diseases","Myocardial Ischemia","Cardiovascular Diseases","Coronary Artery Disease"],"enrollment":65,"completionDate":"2016-06"},{"nctId":"NCT01489761","phase":"PHASE4","title":"LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery)","status":"TERMINATED","sponsor":"Seung-Jung Park","startDate":"2012-01","conditions":["Coronary Artery Disease"],"enrollment":302,"completionDate":"2017-02-14"},{"nctId":"NCT03056118","phase":"PHASE4","title":"Optimal Duration of Clopidogrel in Second-Generation Drug-Eluting Stents","status":"COMPLETED","sponsor":"Gangnam Severance Hospital","startDate":"2011-05-02","conditions":["Ischemic Heart Disease"],"enrollment":1368,"completionDate":"2015-09-07"},{"nctId":"NCT02175706","phase":"NA","title":"DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity","status":"UNKNOWN","sponsor":"Thorax Centrum Twente","startDate":"2010-11","conditions":["Coronary Artery Disease","Angina Pectoris","Unstable Angina Pectoris","Acute Coronary Syndrome","Coronary Stenosis","Coronary Restenosis"],"enrollment":1811,"completionDate":"2017-06"},{"nctId":"NCT02508714","phase":"NA","title":"Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents","status":"UNKNOWN","sponsor":"Thorax Centrum Twente","startDate":"2016-10-07","conditions":["Coronary Artery Disease","Angina Pectoris","Unstable Angina Pectoris","Acute Coronary Syndrome","Coronary Stenosis","Coronary Restenosis"],"enrollment":2470,"completionDate":"2019-03"},{"nctId":"NCT01443754","phase":"","title":"Hybrid Revascularisation by Combined Coronary Artery Bypass Graft (CABG) and PCI in Multivessel Coronary Disease","status":"TERMINATED","sponsor":"Ettore Sansavini Health Science Foundation","startDate":"2011-09","conditions":["Coronary Artery Disease (CAD)"],"enrollment":50,"completionDate":"2016-04"},{"nctId":"NCT01132456","phase":"NA","title":"RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2010-06","conditions":["Ischemic Heart Disease","Coronary Stenosis","Cardiovascular Diseases","Arteriosclerosis","Coronary Artery Disease"],"enrollment":312,"completionDate":"2016-04"},{"nctId":"NCT00726453","phase":"NA","title":"The Medtronic RESOLUTE US Clinical Trial","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2008-07","conditions":["Coronary Artery Disease"],"enrollment":1516,"completionDate":"2016-03"},{"nctId":"NCT01826552","phase":"PHASE4","title":"Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2013-09","conditions":["Coronary Artery Disease","Coronary Heart Disease","Stable Angina","Unstable Angina","ST-segment Elevation Myocardial Infarction","Non-ST-segment Elevation Myocardial Infarction"],"enrollment":372,"completionDate":"2015-06"},{"nctId":"NCT02452736","phase":"PHASE3","title":"Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2015-05","conditions":["Ischemic Heart Disease","Cardiovascular Diseases","Arteriosclerosis","Coronary Artery Disease"],"enrollment":205,"completionDate":"2015-12"},{"nctId":"NCT02415452","phase":"","title":"Researches of Retinal Artery Lesions and Acute Coronary Syndrome","status":"UNKNOWN","sponsor":"Capital Medical University","startDate":"2006-07","conditions":["Acute Coronary Syndrome"],"enrollment":660,"completionDate":"2018-01"},{"nctId":"NCT01069003","phase":"PHASE4","title":"EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2010-04","conditions":["Coronary Artery Disease"],"enrollment":2272,"completionDate":"2014-04"},{"nctId":"NCT01325935","phase":"PHASE4","title":"Optimal Duration of DAPT Following Treatment With Endeavor (Zotarolimus-eluting Stent) in Real-world Japanese Patients","status":"COMPLETED","sponsor":"Associations for Establishment of Evidence in Interventions","startDate":"2011-04","conditions":["Coronary Artery Disease"],"enrollment":1187,"completionDate":"2013-12"},{"nctId":"NCT01113372","phase":"PHASE4","title":"Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor - Optimize Trial","status":"COMPLETED","sponsor":"Cardiovascular Research Center, Brazil","startDate":"2010-04","conditions":["Coronary Artery Disease"],"enrollment":3119,"completionDate":"2015-07"},{"nctId":"NCT00623441","phase":"","title":"E-Five Registry: A World-Wide Registry With The Endeavor Zotarolimus Eluting Coronary Stent","status":"COMPLETED","sponsor":"Medtronic Cardiac Rhythm and Heart Failure","startDate":"2005-09","conditions":["Coronary Artery Disease"],"enrollment":8314,"completionDate":"2009-02"},{"nctId":"NCT00694005","phase":"PHASE4","title":"Choice Of Optimal Strategy For Bifurcation Lesions With Normal Side Branch","status":"COMPLETED","sponsor":"Seung-Jung Park","startDate":"2008-01","conditions":["Coronary Artery Disease"],"enrollment":504,"completionDate":"2015-01"},{"nctId":"NCT00693251","phase":"PHASE4","title":"Optimal Stenting Strategy For True Bifurcation Lesions","status":"COMPLETED","sponsor":"Seung-Jung Park","startDate":"2008-01","conditions":["Coronary Artery Disease"],"enrollment":420,"completionDate":"2015-06"},{"nctId":"NCT01747356","phase":"NA","title":"Efficacy and Safety of RESOLUTE Zotarolimus-Eluting Stent in Treatment of Chinese Diabetic Coronary Lesions","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2013-02","conditions":["Coronary Artery Disease","Diabetes"],"enrollment":1000,"completionDate":"2015-11"},{"nctId":"NCT01066650","phase":"PHASE4","title":"The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting Stent Study in Twente","status":"COMPLETED","sponsor":"Foundation of Cardiovascular Research and Education Enschede","startDate":"2008-06","conditions":["Coronary Artery Disease","Angina Pectoris","Unstable Angina Pectoris","Coronary Stenosis","Coronary Restenosis"],"enrollment":1391,"completionDate":"2012-09"},{"nctId":"NCT01331707","phase":"PHASE4","title":"DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity in an All Comers Population","status":"COMPLETED","sponsor":"Foundation of Cardiovascular Research and Education Enschede","startDate":"2010-11","conditions":["Acute Coronary Syndrome","Angina Pectoris","Angina, Unstable","Myocardial Infarction","Coronary Artery Disease","Coronary Stenosis","Coronary Restenosis"],"enrollment":1811,"completionDate":"2013-12"},{"nctId":"NCT01972022","phase":"PHASE4","title":"TRANSFORM OCT TRiple Assessment of Neointima Stent FOrmation to Reabsorbable polyMer With Optical Coherence Tomography","status":"UNKNOWN","sponsor":"A.O. Ospedale Papa Giovanni XXIII","startDate":"2013-11","conditions":["Coronary Artery Lesions"],"enrollment":90,"completionDate":"2016-09"},{"nctId":"NCT01539603","phase":"PHASE2","title":"Comparison of Drug Eluting Balloon and Drug Eluting Stent","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2011-04","conditions":["Coronary Artery Disease","Stable Angina","Unstable Angina","NSTEMI"],"enrollment":180,"completionDate":"2015-02"},{"nctId":"NCT00428454","phase":"PHASE3","title":"Sirolimus-eluting vs Zotarolimus-eluting Stents for Chronic Total Coronary Occlusions","status":"COMPLETED","sponsor":"R&D Cardiologie","startDate":"2007-01","conditions":["Coronary Artery Disease","Coronary Disease","Coronary Stenosis"],"enrollment":301,"completionDate":"2015-06"},{"nctId":"NCT00927940","phase":"NA","title":"RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2009-03","conditions":["Arterial Occlusive Diseases","Myocardial Ischemia","Cardiovascular Diseases","Coronary Artery Disease"],"enrollment":100,"completionDate":"2015-02"},{"nctId":"NCT00846846","phase":"PHASE4","title":"PROTECT Continued Access Post Marketing Surveillance Trial","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2009-01","conditions":["Coronary Artery Disease, Autosomal Dominant, 1"],"enrollment":1018,"completionDate":"2015-03"},{"nctId":"NCT02360423","phase":"PHASE3","title":"Safety and Efficacy of the CRE8 Stent for the Treatment of De Novo Coronary Artery Lesions","status":"UNKNOWN","sponsor":"CID S.p.A.","startDate":"2014-11","conditions":["Coronary Artery Disease"],"enrollment":430,"completionDate":"2021-04"},{"nctId":"NCT00609947","phase":"NA","title":"Endeavor Zotarolimus - Eluting Stent in the Treatment Lesions in Small Native Coronary Arteries.","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2008-01","conditions":["Coronary Artery Disease"],"enrollment":241,"completionDate":"2013-09"},{"nctId":"NCT00476957","phase":"PHASE4","title":"Randomized Study Comparing Endeavor With Cypher Stents (PROTECT)","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2007-06","conditions":["Ischemic Heart Disease"],"enrollment":8709,"completionDate":"2014-07"},{"nctId":"NCT01293773","phase":"PHASE4","title":"Outcome of Second Generation Drug-eLuting Stents in Patients With Diabetes Mellitus","status":"WITHDRAWN","sponsor":"Policlinico Casilino ASL RMB","startDate":"2010-10","conditions":["Coronary Artery Disease","Diabetes Mellitus"],"enrollment":0,"completionDate":"2012-12"},{"nctId":"NCT01347554","phase":"PHASE4","title":"Efficacy of Everolimus-Eluting Versus Zotarolimus-Eluting Sten for Coronary Lesions in Acute Myocardial Infarction","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2009-01","conditions":["Myocardial Infarction"],"enrollment":461,"completionDate":"2013-03"},{"nctId":"NCT01186107","phase":"PHASE4","title":"Comparison of Zotarolimus-Eluting Stent vs Sirolimus-Eluting Stent for Diabetic Patients","status":"COMPLETED","sponsor":"Seung-Jung Park","startDate":"2010-08","conditions":["Coronary Artery Disease","Diabetes"],"enrollment":256,"completionDate":"2013-07"},{"nctId":"NCT00617084","phase":"PHASE4","title":"Randomized, Two-arm, Non-inferiority Study Comparing Endeavor-Resolute Stent With Abbot Xience-V Stent","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2008-04","conditions":["Coronary Artery Disease"],"enrollment":2292,"completionDate":"2014-02"},{"nctId":"NCT00492908","phase":"PHASE4","title":"Randomized Trial Comparing Titan Stent With Zotarolimus-Eluting Stent","status":"COMPLETED","sponsor":"University of Bern","startDate":"2007-06","conditions":["Coronary Heart Disease"],"enrollment":303,"completionDate":"2013-08"},{"nctId":"NCT00590174","phase":"PHASE4","title":"Clopidogrel Use and Long-term Safety After Drug-Eluting Stents Implantation","status":"COMPLETED","sponsor":"Seung-Jung Park","startDate":"2007-10","conditions":["Coronary Artery Disease"],"enrollment":1175,"completionDate":"2010-04"},{"nctId":"NCT02018991","phase":"PHASE4","title":"Late Acquired Malaposition and Different Polymers","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2010-10","conditions":["Late Acquired Stent Malaposition"],"enrollment":69,"completionDate":"2013-08"},{"nctId":"NCT01267734","phase":"PHASE4","title":"Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2010-06","conditions":["Coronary Heart Disease"],"enrollment":3750,"completionDate":"2015-06"},{"nctId":"NCT01956448","phase":"NA","title":"SORT-OUT VI - Randomized Clinical Comparison of Biomatrix Flex® and Resolute Integrity®","status":"COMPLETED","sponsor":"Aarhus University Hospital Skejby","startDate":"2011-03","conditions":["Coronary Artery Disease","Angina Pectoris"],"enrollment":2800,"completionDate":"2012-07"},{"nctId":"NCT00660478","phase":"PHASE3","title":"Randomized Clinical Comparison of the Endeavor and the Cypher Coronary Stents in Non-selected Angina Pectoris Patients","status":"COMPLETED","sponsor":"Evald Hoej Christiansen","startDate":"2006-01","conditions":["Ischemic Heart Disease"],"enrollment":2342,"completionDate":"2009-10"},{"nctId":"NCT01391871","phase":"","title":"Vascular Healing of DES at 3 Months","status":"COMPLETED","sponsor":"University of Turku","startDate":"2011-06","conditions":["Acute Coronary Syndrome"],"enrollment":46,"completionDate":"2013-07"},{"nctId":"NCT00598637","phase":"PHASE4","title":"Drug-eluting Stents to Treat Unprotected Coronary Left Main Disease","status":"COMPLETED","sponsor":"Deutsches Herzzentrum Muenchen","startDate":"2007-12","conditions":["Coronary Disease"],"enrollment":650,"completionDate":"2013-02"},{"nctId":"NCT01887704","phase":"NA","title":"Effect of Rotablator on Balloon Resistant Calcified Coronary Lesion","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2010-01","conditions":["Coronary Artery Disease"],"enrollment":240,"completionDate":"2013-05"},{"nctId":"NCT01869842","phase":"NA","title":"Randomized Controlled Study of the Traditional Percutaneous Coronary Intervention and Intervention Using Optical Coherence Tomography of Incomplete Stent Adhesion and Extent of the Formation of Neointima by Resolute Zotarolimus-eluting Stent Insertion","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2011-12","conditions":["Coronary Artery Disease","Stable Angina","Unstable Angina"],"enrollment":115,"completionDate":"2016-12"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"UNII":"H4GXR80IZE","CHEBI":"CHEBI:135897","INN_ID":"8644","UMLSCUI":"C1700035","ChEMBL_ID":"CHEMBL219410","KEGG_DRUG":"D06669","PUBCHEM_CID":"9876378","SNOMEDCT_US":"429803003","IUPHAR_LIGAND_ID":"7974","MESH_SUPPLEMENTAL_RECORD_UI":"C489443"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","halfLife":"35.0 hours","clearance":"0.67 mL/min/kg","fractionUnbound":"0.26%","volumeOfDistribution":"1.3 L/kg"},"publicationCount":776,"therapeuticAreas":["Immunology"],"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 25","pmid":"41879601","title":"\"Roundabout\" Bailout Stenting for Subacute Right Coronary Artery Obstruction After Self-Expandable Transcatheter Aortic Valve Replacement.","journal":"JACC. Case reports"},{"date":"2026 Dec","pmid":"41631490","title":"Comparative effectiveness of percutaneous coronary intervention strategies for coronary small-vessel disease: a network meta-analysis of randomized trials.","journal":"Annals of medicine"},{"date":"2026 Feb","pmid":"41561403","title":"Short dual antiplatelet therapy after PCI with Resolute Onyx drug-eluting stents in high bleeding risk patients: One-year outcomes from a South Asian cohort.","journal":"American heart journal plus : cardiology research and practice"},{"date":"2025 Nov","pmid":"41230396","title":"Complex all-comers and patients with diabetes and prediabetes treated with Xience Sierra everolimus-eluting stents: COASTLINE high-risk.","journal":"European heart journal open"},{"date":"2025 Oct 25","pmid":"41194756","title":"Economic Outcomes and Quality of Life After CABG or PCI for Multivessel Disease: The FAME 3 Trial.","journal":"Journal of the American College of Cardiology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"ZOTAROLIMUS","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Zotarolimus is a small molecule inhibitor of the FK506-binding protein 1A, used in drug-eluting stents such as the Resolute Integrity Stent to treat conditions including coronary artery disease and myocardial ischemia. It is classified as an inhibitor and has been studied in clinical trials for various coronary artery disease-related conditions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}